Novo Nordisk country sites
USA
Argentina
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
Chile
China
Croatia
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Greece
Hungary
Iraq
Ireland
Israel
Italy
Japan
Korea (Republic)
Latvia
Lebanon
Lithuania
Mexico
Netherlands
New Zealand
Norway
Pakistan
Poland
Portugal
Romania
Russian Federation
Serbia
Slovak Republic
Slovenia
South Africa
Spain
Sweden
Switzerland
Syria
Taiwan
Thailand
Turkey
Ukraine
United Kingdom
Other Novo Nordisk sites
Changing diabetes
DAWN study
Hagedorn Research Institute
Diabetes4Patients
Diabetes Barometer
Changing diabetes bus
Media prize
World diabetes day
School challenge
Improve Control
HRT for HCPs
HRT for women
HRT congresses & symposia
Healthcare Professionals
Patients
Investors
Media
R&D
Jobs
Sustainability
About us
Overview
Who we are
About Novo Nordisk
Management
Corporate governance
Ownership
Facts and figures
Global Offices
Products and services
Research and development
History
What we do
Diabetes care
Haemostasis management
Growth hormone therapy
HRT
How we perform
Access to health
Benchmarks and ratings
Bioethics
Community involvement
Economic footprint
Environmental impacts
Financial performance
Interactive charts
Key performance data
Key performance indicators
People at work
Public policy activities
Reports from production areas
Supply chain management
How we work
The Novo Nordisk Way
Leading the fight against diabetes
Key challenges
Stakeholder engagement
Accounting for performance
Definitions
How we are accountable
Accounting policies
Auditor's Independence Statement
Assurance statement
What assures?
Materiality
GRI
Global Compact index
Stakeholder feedback
Download full report
Financial highlights
Conference call
R & D pipeline
The share
Corporate governance
Contact IR
Rate this page
Send to a friend
Print
Conference Call
Teleconference / FY 2004 - 28 January 2005
Listen to the conference call
Download the slides for this conference call
Back to top
Stock exchange announcement
Full year results 2004
GRI
Overview of the full 'in accordance' reporting
Case stories
Results with stakeholders